New Frontier of molecular mechanism of vascular smooth muscle contraction.
New Frontier of molecular mechanism of vascular smooth muscle contraction.
批准号:
17590212
负责人:
NAKAMURA Akio
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
平滑肌肌球蛋白轻链激酶(SmMLCK)是钙调素依赖性蛋白激酶家族,催化肌球蛋白调节轻链(MLc 20)的磷酸化,在激活平滑肌细胞肌动球蛋白相关收缩性中发挥重要作用。SmMLCK还表现出肌动蛋白结合和肌球蛋白结合活性,除了这种激酶活性。这些被称为非激酶活性。前者抑制肌球蛋白ATP酶活性,后者激活。为了阐明这些分子机制,我们尝试在大肠杆菌中制备重组SmMLCK。利用冷激启动子构建的新型细菌表达系统,成功地在5-10 mg/L培养基中高效表达了全长重组SmMLCK。重组SmMLCK是可溶性形式,其磷酸化MLc 20。它也有非激酶活性,如肌动蛋白结合和捆绑活动。重组SmMLCK,与已知的SmMLCK的特性,定量表达,是分析MLCK的结构和功能的第一步。也有报道称,SmMLCK受几种激酶的调节,但尚不清楚上游信号如何调节SmMLCK。我们发现从牛胃中纯化的SmMLCK已经被内源性激酶部分磷酸化。通常,重组SmMLCK在细菌中不被磷酸化。因此,我们通过使用重组SmMLCK和各种Ser/Thr激酶来检测哪种激酶磷酸化MLCK。重组SmMLCK被MAPK、PAK、PKA、PKC磷酸化,ROCK 1在无Ca/钙调素的情况下被磷酸化。除PKA外,其它激酶在Ca/钙调素存在下不能掺入SmMLCK。我们通过4000 Q Trap LC/MS/MS确定了这些磷酸化位点。这些上游激酶对MLCK的磷酸化可能在平滑肌细胞肌动球蛋白相关收缩性的调节中具有重要的生理意义。
英文摘要
Smooth muscle myosin light chain kinase (SmMLCK), family of calmodulin-dependent protein kinases, catalyzes the phosphorylation of regulatory light chain (MLc 20) of myosin, and plays an important role in activating actomyosin-linked contractility in smooth muscle cell. SmMLCK also exhibits actin-binding and myosin-binding activities in addition to this kinase activity. These are called non-kinase activity. The former inhibits myosin ATPase activity, and latter activates. In order to clarify these molecule mechanisms, we tried making the recombinant SmMLCK in E.coli. We succeeded in the high-level expression (5-10 mg/L culture medium) of full-length recombinant SmMLCK by new bacterial expression system using the cold shock promoter. Recombinant SmMLCK was a soluble form and it phosphorylated MLc20. It also had non-kinase activity such as actin-binding and -bundling activities. Recombinant SmMLCK, with the properties known for SmMLCK, was quantifiably expressed and is the first step in analyzing the structure and function of MLCK. It is also reported that SmMLCK is regulated by several kinases, but it is not clear how upstream signaling regulates SmMLCK. We found that the purified SmMLCK from the bovine stomach was already partially phosphorylated by endogenous kinase. Usually the recombinant SmMLCK is not phosphorylated in bacteria. Therefore we examined which kind of kinase phosphorylated MLCK by using the recombinant SmMLCK and various Ser/Thr kinases. Recombinant SmMLCK was phosphorylated by MAPK, PAK, PKA, PKC and ROCK1 phosphorylated in the absence of Ca/calmodulin. Except for the PKA, other kinase could not incorporate into recombinant SmMLCK in the presence of Ca/calmodulin. We determined these phosphorylation sites by the 4000 Q Trap LC/MS/MS. The phosphorylation of MLCK by those upstream kinases may be physiologically important in regulating of actomyosin-linked contractility in smooth muscle cell.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1161/01.atv.0000174130.75958.b7
发表时间:
2005-09-01
期刊:
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
影响因子:
8.7
作者:
[Murata, T, Hori, M, Ozaki, H]
通讯作者:
Ozaki, H
DOI:
10.1152/ajpheart.00901.2005
发表时间:
2006-09-01
期刊:
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
影响因子:
4.8
作者:
[Li, Sheng, Tanaka, Hideyuki, Kohama, Kazuhiro]
通讯作者:
Kohama, Kazuhiro
Vascular edothelium has a local anti-adenovirus vector system and glucocorticoid optimizes its gene transduction.
血管内皮细胞具有局部抗腺病毒载体系统,糖皮质激素优化其基因转导。
DOI:
--
发表时间:
2005
期刊:
Arterioscler.Thromb.Vasc.Biol. 25
影响因子:
--
作者:
[Murata, T., et al.]
通讯作者:
et al.
Class-specific binding of two aminoacyl-tRNA synthetases to annexin, a Ca2+- and phospholipid-binding protein.
两种氨酰基-tRNA 合成酶与膜联蛋白(一种 Ca2 和磷脂结合蛋白)的类特异性结合。
DOI:
--
发表时间:
2005
期刊:
Cell Structure and Function
影响因子:
1.5
作者:
[T. Shirakawa, A. Nakamura, K. Kohama, M. Hirakata, S. Ogihara]
通讯作者:
S. Ogihara
DOI:
10.1254/jphs.sc0060104
发表时间:
2006
期刊:
Journal of pharmacological sciences
影响因子:
3.5
作者:
[Takeshi Katayama;S. Yoshiyama;Hideyuki Tanaka;Hong Hui Wang;A. Nakamura;K. Kohama]
通讯作者:
Takeshi Katayama;S. Yoshiyama;Hideyuki Tanaka;Hong Hui Wang;A. Nakamura;K. Kohama
共 7 条
Exploring the causes of arteriosclerosis from the expressed microRNA by the dedifferentiation of vascular smooth muscle cells.
-
批准号:23590295
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:NAKAMURA Akio
-
依托单位:
Object Recognition System through Multimodal Interaction with Human Users and Environment
-
批准号:20700186
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.58万
-
财政年份:2008
-
负责人:NAKAMURA Akio
-
依托单位:
Mechanism of transformation of vascular smooth muscle cell-MicroRNA as regulating factor
-
批准号:19590240
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:NAKAMURA Akio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
探索肌球蛋白(myosin)成员在马铃薯纺锤形块茎类病毒(PSTVd)细胞内运动中的作用
-
批准号:
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2024
-
负责人:吴健
-
依托单位:
抗磷脂综合征新型致病性抗体-抗Myosin5A抗体临床价值的多中心验证研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:5.0万元
-
批准年份:2024
-
负责人:刘婷婷
-
依托单位:
肌球蛋白Myosin VI调节自噬影响ER阳性乳腺癌进展和他莫昔芬治疗敏感性的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:周珏宇
-
依托单位:
Myosin19乳酰化致线粒体内嵴结构重排在脓毒症心脏功能障碍中的作用机制
-
批准号:82300561
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:佘汉
-
依托单位:
PbIMC1g通过调控actin-myosin motor功能介导动合子滑行和侵袭的分子机制研究
-
批准号:82372280
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:朱晓彤
-
依托单位:
MyosinⅡ磷酸化介导Piezo1通道激活在七氟烷致髓鞘发育障碍中的作用机制研究
-
批准号:82301366
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:蒋璐璐
-
依托单位:
Myosin II-Piezo1-Yap介导机械应力调控膀胱平滑肌细胞与脱细胞基质补片(SIS)交互作用促进功能性膀胱组织再生的研究
-
批准号:82270720
-
项目类别:面上项目
-
资助金额:70万元
-
批准年份:2022
-
负责人:罗德毅
-
依托单位:
Myosin-II-PDGFRβ调控肿瘤相关成纤维细胞与巨噬细胞互作介导直肠癌放疗抵抗的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:黄莉莉
-
依托单位:
Myosin-Vb功能缺失引起溶酶体铁过载介导微绒毛包涵体病肠绒毛萎缩的机制及干预研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:冷长森
-
依托单位:
Myosin VI参与听觉发生及其突变致聋的生理病理机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:李耕林
-
依托单位: